SAB Biotherapeutics, Inc. - Equity Warrant - Kunci Kira-kira (Quarterly)

SAB Biotherapeutics, Inc. - Equity Warrant
US ˙ NasdaqCM ˙ US78397T1117
SIMBOL INI TIDAK AKTIF LAGI

Kunci Kira-kira (Quarterly)

SAB Biotherapeutics, Inc. - Equity Warrant Kunci Kira-kira menunjukkan baki akaun untuk syarikat pada masa yang tepat. Data Kunci Kira-kira termasuk Aset, Aset Semasa, Aset Tetap, Hartanah, Loji dan Peralatan (PPE), Inventori, Aset Tidak Ketara, Liabiliti, Liabiliti Semasa, Hutang, Hutang Pajakan Modal, Saham Biasa, Perolehan Tertahan, Saham Perbendaharaan dan Ekuiti Pemegang Saham.

Semua nombor adalah kali 1,000,000.00 kecuali setiap unit saham.

2020
12-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Tunai 13 10 11 33 22 17 8 15 13 8 2 57 14 17 9 9 6 4
Perubahan (%) -18.86 5.06 208.88 -32.52 -25.85 -49.86 80.59 -13.20 -40.47 -68.80 2,232.16 -75.19 22.86 -46.81 -2.98 -36.61 -34.54
Aset Semasa 34 28 22 50 36 28 22 22 15 9 3 59 47 40 33 24 16 9
Perubahan (%) -19.41 -21.11 129.11 -27.94 -23.28 -20.07 -0.38 -31.97 -40.09 -65.27 1,783.39 -20.30 -15.70 -17.80 -26.88 -31.50 -42.88
Aset 57 54 51 81 67 59 53 51 43 35 28 84 71 62 54 44 38 30
Perubahan (%) -4.11 -5.68 58.69 -16.85 -12.33 -11.24 -3.05 -16.17 -16.94 -20.05 196.23 -14.97 -13.28 -13.08 -17.85 -13.75 -20.96
Liabiliti 18 16 16 43 26 22 22 20 18 16 13 27 19 16 17 18 17 18
Perubahan (%) -9.00 0.63 165.31 -38.45 -15.95 -0.68 -9.31 -7.95 -13.92 -16.82 103.68 -30.37 -14.97 7.12 7.88 -8.30 8.38
Ekuiti 39 38 35 39 41 37 31 31 24 20 15 57 53 46 37 26 21 12
Perubahan (%) -1.92 -8.31 9.90 7.03 -10.03 -17.50 1.42 -21.43 -19.20 -22.62 275.59 -7.81 -12.69 -19.99 -29.63 -17.57 -43.87
Liabiliti Dan Ekuiti Saham 57 54 51 81 67 59 53 51 43 35 28 84 71 62 54 44 38 30
Perubahan (%) -4.11 -5.68 58.69 -16.85 -12.33 -11.24 -3.05 -16.17 -16.94 -20.05 196.23 -14.97 -13.28 -13.08 -17.85 -13.75 -20.96

Source: Capital IQ

Other Listings
US:SABSW USD0.03
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista